Envestnet Portfolio Solutions’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,209
Closed -$352K 1515
2025
Q3
$352K Sell
5,209
-1,124
-18% -$74.6K ﹤0.01% 1177
2025
Q2
$413K Buy
6,333
+128
+2% +$7.67K ﹤0.01% 1186
2025
Q1
$383K Sell
6,205
-8,412
-58% -$557K ﹤0.01% 1167
2024
Q4
$1.05M Sell
14,617
-5,855
-29% -$457K ﹤0.01% 902
2024
Q3
$1.67M Buy
20,472
+4,489
+28% +$359K 0.01% 722
2024
Q2
$1.19M Sell
15,983
-602
-4% -$45.1K ﹤0.01% 805
2024
Q1
$1.29M Buy
16,585
+4,392
+36% +$327K ﹤0.01% 767
2023
Q4
$871K Sell
12,193
-817
-6% -$56.9K ﹤0.01% 831
2023
Q3
$903K Buy
+13,010
New +$983K ﹤0.01% 774

Other funds holding HOLX

Envestnet Portfolio Solutions's HOLX Position: Q4 2025 in Review

Envestnet Portfolio Solutions sold out of Hologic (HOLX) in Q4 2025, closing a stake of 5,209 shares — an estimated $352K sold.

Envestnet Portfolio Solutions first reported a position in HOLX in Q3 2023 and held it in 9 quarters. The position peaked at $1.67M in Q3 2024. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

  • Envestnet Portfolio Solutions reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
  • Envestnet Portfolio Solutions sold 5,209 Hologic shares in Q4 2025, an estimated $352K.
  • Envestnet Portfolio Solutions first reported a position in Hologic in Q3 2023 and held it in 9 quarters.
  • Envestnet Portfolio Solutions's Hologic position peaked at $1.67M in Q3 2024.
  • 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Envestnet Portfolio Solutions's 13F filing for Q4 2025, filed 6 Feb 2026.